EP3303348 - NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 10.07.2020 Database last updated on 26.07.2024 | |
Former | The patent has been granted Status updated on 05.07.2019 | ||
Former | Grant of patent is intended Status updated on 17.02.2019 | ||
Former | Request for examination was made Status updated on 09.03.2018 | ||
Former | The international publication has been made Status updated on 02.12.2016 | Most recent event Tooltip | 10.07.2020 | No opposition filed within time limit | published on 12.08.2020 [2020/33] | Applicant(s) | For all designated states Theravance Biopharma R&D IP, LLC 901 Gateway Boulevard South San Francisco, CA 94080 / US | [2018/15] | Inventor(s) | 01 /
HUDSON, Ryan 1454 Walbrook Drive San Jose, California 95129 / US | 02 /
KOZAK, Jennifer 771 Prairie Creek Drive Pacifica, California 94044 / US | 03 /
FATHEREE, Paul R. 921 Minnesota Street San Francisco, California 94107 / US | 04 /
PODESTO, Dante D. 1122 Trinity Avenue Modesto, California 95350 / US | 05 /
BRANDT, Gary E.L. 2160 Buena Vista Avenue Alameda, California 94501 / US | 06 /
FLEURY, Melissa 47D Joy Avenue Brisbane, California 94005 / US | 07 /
BEAUSOLEIL, Anne-Marie 600 Brewster Avenue, Apt. 306 Redwood City, California 94063 / US | 08 /
HUANG, Xiaojun 5978 Bollinger Road San Jose, CA 95129 / US | 09 /
THALLADI, Venkat R. 888 Foster City Boulevard Apt. E3 Foster City, California 94404 / US | [2019/32] |
Former [2018/15] | 01 /
HUDSON, Ryan 1454 Walbrook Drive San Jose, California 95129 / US | ||
02 /
KOZAK, Jennifer 771 Prairie Creek Drive Pacifica, California 94044 / US | |||
03 /
FATHEREE, Paul R. 921 Minnesota Street San Francisco, California 94107 / US | |||
04 /
PODESTO, Dante D. 1122 Trinity Avenue Modesto, California 95350 / US | |||
05 /
BRANDT, Gary E.L. 2160 Buena Vista Avenue Alameda, California 94501 / US | |||
06 /
FLEURY, Melissa 47D Joy Avenue Brisbane, California 94005 / US | |||
07 /
BEAUSOLEIL, Anne-Marie 600 Brewster Avenue, Apt. 306 Redwood City, California 94063 / US | |||
08 /
HUANG, Xiaojun 513 Granger Terrace Sunnyvale, California 94087 / US | |||
09 /
THALLADI, Venkat R. 888 Foster City Boulevard Apt. E3 Foster City, California 94404 / US | Representative(s) | Abel & Imray LLP Westpoint Building James Street West Bath BA1 2DA / GB | [N/P] |
Former [2018/15] | Abel & Imray Westpoint Building James Street West Bath BA1 2DA / GB | Application number, filing date | 16728495.9 | 26.05.2016 | [2018/15] | WO2016US34243 | Priority number, date | US201562167694P | 28.05.2015 Original published format: US 201562167694 P | US201662312273P | 23.03.2016 Original published format: US 201662312273 P | [2018/15] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2016191524 | Date: | 01.12.2016 | Language: | EN | [2016/48] | Type: | A1 Application with search report | No.: | EP3303348 | Date: | 11.04.2018 | Language: | EN | The application published by WIPO in one of the EPO official languages on 01.12.2016 takes the place of the publication of the European patent application. | [2018/15] | Type: | B1 Patent specification | No.: | EP3303348 | Date: | 07.08.2019 | Language: | EN | [2019/32] | Search report(s) | International search report - published on: | EP | 01.12.2016 | Classification | IPC: | C07D519/00, A61K31/439, A61P1/04 | [2018/15] | CPC: |
C07D519/00 (EP,CN,IL,US);
C07D471/06 (KR);
A61K31/4375 (KR);
A61K31/46 (EP,IL,KR,US);
A61K45/06 (IL,US);
A61P1/00 (EP,IL);
A61P1/04 (EP,IL);
A61P29/00 (EP,IL);
A61P43/00 (EP,IL);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2018/15] | Extension states | BA | 27.11.2017 | ME | 27.11.2017 | Validation states | MA | Not yet paid | MD | Not yet paid | Title | German: | NAPHTHYRIDIN- VERBINDUNGEN ALS JAK KINASE INHIBITOREN | [2019/07] | English: | NAPHTHYRIDINE COMPOUNDS AS JAK KINASE INHIBITORS | [2018/15] | French: | COMPOSÉS DE NAPHTHYRIDINE EN TANT QU'INHIBITEURS DE KINASES JAK[ | [2019/07] |
Former [2018/15] | NAPHTHYRIDINVERBINDUNGEN ALS JAK-KINASE-INHIBITOREN | ||
Former [2018/15] | COMPOSÉS DE NAPHTYRIDINE EN TANT QU'INHIBITEURS DE LA KINASE JAK | Entry into regional phase | 27.11.2017 | National basic fee paid | 27.11.2017 | Designation fee(s) paid | 27.11.2017 | Examination fee paid | Examination procedure | 27.11.2017 | Examination requested [2018/15] | 27.11.2017 | Date on which the examining division has become responsible | 31.07.2018 | Amendment by applicant (claims and/or description) | 18.02.2019 | Communication of intention to grant the patent | 27.06.2019 | Fee for grant paid | 27.06.2019 | Fee for publishing/printing paid | 27.06.2019 | Receipt of the translation of the claim(s) | Divisional application(s) | EP19182836.7 / EP3569604 | Opposition(s) | 03.06.2020 | No opposition filed within time limit [2020/33] | Fees paid | Renewal fee | 29.05.2018 | Renewal fee patent year 03 | 28.05.2019 | Renewal fee patent year 04 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [A]WO2006067614 (PFIZER PROD INC [US], et al) [A] 1-33* the whole document *; | [A]WO2007071348 (HOFFMANN LA ROCHE [CH], et al) [A] 1-33 * the whole document *; | [A]WO2008119792 (PALAU PHARMA SA [ES], et al) [A] 1-33 * the whole document * | by applicant | - DANESE ET AL., N ENGL J MED, (2011), vol. 365, pages 1713 - 1725 | - ALLEZ ET AL., J CROHN'S COLITIS, (2010), vol. 4, pages 355 - 366 | - RUTGEERTS ET AL., NENGL J MED, (2005), vol. 353, pages 2462 - 2476 | - TARGOWNIK ET AL., AM J GASTROENTEROL, (2012), vol. 107, pages 1228 - 1235 | - STROBER ET AL., GASTROENTEROL, (2011), vol. 140, pages 1756 - 1767 | - CLARK ET AL., J MED CHEM, (2014), vol. 57, pages 5023 - 5038 | - T. W. GREENE; G. M. WUTS, Protecting Groups in Organic Synthesis, WILEY | - REIMUND ET AL., J CLIN IMMUNOLOGY, (1996), vol. 16, pages 144 - 150 | - WOYWODT ET AL., EUR J GASTROENTEROLOGY HEPATOLOGY, (1999), vol. 11, pages 267 - 276 | - KUMAWAT ET AL., MOL IMMUNOLOGY, (2013), vol. 55, pages 355 - 364 | - WEINBRAND-GOICHBERG ET AL., IMMUNOL RES, (2013), vol. 56, pages 249 - 260 | - COGHILL ET AL., BLOOD, (2001), vol. 117, pages 3268 - 3276 | - STALLMACH ET AL., INT J COLORECTAL DIS, (2004), vol. 19, pages 308 - 315 | - ZHOU ET AL., AUTOIMMUN REV, (2012), vol. 11, pages 699 - 704 | - DENITTO ET AL., WORLD J GASTROENTEROL, (2009), vol. 15, pages 4609 - 4614 | - YANO ET AL., J TRANSLATION MED, (2014), vol. 12, page 191 | - YAMAMOTO ET AL., DIG LIVER DIS, (2008), vol. 40, pages 253 - 259 | - MOZAFFARI ET AL., EXPERT OPIN. BIOL. THER., (2014), vol. 14, pages 583 - 600 | - DANESE, GUT, (2012), vol. 61, pages 918 - 932 | - LAM ET AL., IMMUNOTHERAPY, (2014), vol. 6, pages 963 - 971 | - SHELDRICK, ACTA CRYST., (2015), vol. C71, pages 3 - 8 | - HELLER ET AL., IMMUNOLOGY, (2002), vol. 17, pages 629 - 638 | - KUDLACZ ET AL., AM. J. OF TRANSPLANTATION, (2004), vol. 4, pages 51 - 57 |